A proteomics analysis of AD revealed that inflammatory markers, including matrix metalloproteinases (MMP1, MMP3, MMP9, and MMP12), Th2-type cytokines, and chemokines, are significantly upregulated in both lesion and non-lesion skin in patients with AD compared with healthy normal skin (28, 29). This evidence concerns the gene MMP1 and Alzheimer disease.